Thomas R Ulich

Title: Thomas R Ulich: Innovator in Modified Corticotropin Releasing Factor Peptides

Introduction

Thomas R Ulich is a notable inventor based in Flushing, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified corticotropin releasing factor peptides. His work has implications for various medical treatments and advancements.

Latest Patents

Thomas R Ulich holds a patent for "Modified corticotropin releasing factor peptides and uses thereof." This invention relates to compounds that include modified corticotrophin releasing factor peptides, specifically urocortin and its related peptides. The patent details the creation of conjugates of these modified peptides with serum components, which are designed to enhance the in vivo circulating half-life and biological activity of the peptides. The methods outlined in the patent also provide approaches for treating and preventing diseases through the administration of these compounds.

Career Highlights

Ulich is associated with Conjuchem, Inc., where he continues to innovate in the field of peptide research. His work has led to advancements that could significantly impact therapeutic strategies for various disorders.

Collaborations

Throughout his career, Thomas R Ulich has collaborated with notable colleagues, including Jean-Philippe Estradier and Karen Thibaudeau. These collaborations have contributed to the development and refinement of his innovative research.

Conclusion

Thomas R Ulich's contributions to the field of modified corticotropin releasing factor peptides highlight his role as a significant inventor. His work not only advances scientific understanding but also holds promise for future medical applications.